{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:02:42Z","timestamp":1785499362255,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00460233"],"award-info":[{"award-number":["RS-2024-00460233"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-24533929"],"award-info":[{"award-number":["RS-2025-24533929"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A2C1009926"],"award-info":[{"award-number":["NRF-2019R1A2C1009926"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02325-3","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:42:12Z","timestamp":1785498132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NKR+CD8+ T cells and iNKT cells protect mice from AOM\/DSS-induced colorectal cancer under conditions of IFN\u03b3-mediated hyperinflammation"],"prefix":"10.1007","volume":"75","author":[{"given":"Hyun Jung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Hoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Van Kaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokmann","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"2325_CR1","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","volume":"140","author":"W Strober","year":"2011","unstructured":"Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756\u201367. https:\/\/doi.org\/10.1053\/j.gastro.2011.02.016.","journal-title":"Gastroenterology"},{"key":"2325_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02166-w","author":"Q Xie","year":"2024","unstructured":"Xie Q, Liu X, Liu R, Pan J, Liang J. Cellular mechanisms of combining innate immunity activation with PD-1\/PD-L1 blockade in treatment of colorectal cancer. Mol Cancer. 2024. https:\/\/doi.org\/10.1186\/s12943-024-02166-w.","journal-title":"Mol Cancer"},{"key":"2325_CR3","doi-asserted-by":"publisher","unstructured":"Van Kaer L, Algood HMS, Singh K, Parekh VV, Greer MJ, Piazuelo MB, et al. CD8alphaalpha(+) innate-type lymphocytes in the intestinal epithelium mediate mucosal immunity. Immunity. 2014;41:451\u201364. https:\/\/doi.org\/10.1016\/j.immuni.2014.08.010.","DOI":"10.1016\/j.immuni.2014.08.010"},{"key":"2325_CR4","doi-asserted-by":"publisher","unstructured":"Chou C, Zhang X, Krishna C, Nixon BG, Dadi S, Capistrano KJ et al. Programme of self-reactive innate-like T cell-mediated cancer immunity. Nature. 2022;605:139\u2013145. https:\/\/doi.org\/10.1038\/s41586-022-04632-1","DOI":"10.1038\/s41586-022-04632-1"},{"key":"2325_CR5","doi-asserted-by":"publisher","unstructured":"Lee SW, Park HJ, Cheon JH, Wu L, Van Kaer L, Hong S. iNKT Cells suppress pathogenic NK1.1(+)CD8(+) T cells in DSS-induced colitis. Front Immunol. 2018;9:2168. https:\/\/doi.org\/10.3389\/fimmu.2018.02168","DOI":"10.3389\/fimmu.2018.02168"},{"key":"2325_CR6","doi-asserted-by":"publisher","unstructured":"Reinhardt RL, Liang HE, Bao K, Price AE, Mohrs M, Kelly BL et al. A novel model for IFN-gamma-mediated autoinflammatory syndromes. J Immunol. 2015;194:2358-68. https:\/\/doi.org\/10.4049\/jimmunol.1401992","DOI":"10.4049\/jimmunol.1401992"},{"key":"2325_CR7","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.1073\/pnas.1332805100","volume":"100","author":"JL Matsuda","year":"2003","unstructured":"Matsuda JL, Gapin L, Baron JL, Sidobre S, Stetson DB, Mohrs M, et al. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc Natl Acad Sci U S A. 2003;100:8395\u2013400. https:\/\/doi.org\/10.1073\/pnas.1332805100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2325_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3389\/fimmu.2018.00519","volume":"9","author":"L Van Kaer","year":"2018","unstructured":"Van Kaer L, Wu L. Therapeutic potential of invariant natural killer T cells in autoimmunity. Front Immunol. 2018;9:519. https:\/\/doi.org\/10.3389\/fimmu.2018.00519.","journal-title":"Front Immunol"},{"key":"2325_CR9","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jid.2020.09.030","volume":"141","author":"HJ Park","year":"2021","unstructured":"Park HJ, Lee SW, Park SH, Van Kaer L, Hong S. Selective expansion of double-negative iNKT cells inhibits the development of atopic dermatitis in Valpha14 TCR transgenic NC\/Nga mice by increasing memory-Type CD8(+) T and regulatory CD4(+) T cells. J Invest Dermatol. 2021;141:1512\u201321. https:\/\/doi.org\/10.1016\/j.jid.2020.09.030.","journal-title":"J Invest Dermatol"},{"key":"2325_CR10","doi-asserted-by":"publisher","first-page":"114948","DOI":"10.1016\/j.celrep.2024.114948","volume":"43","author":"M Lebrusant-Fernandez","year":"2024","unstructured":"Lebrusant-Fernandez M, Ap Rees T, Jimeno R, Angelis N, Ng JC, Fraternali F, et al. IFN-gamma-dependent regulation of intestinal epithelial homeostasis by NKT cells. Cell Rep. 2024;43:114948. https:\/\/doi.org\/10.1016\/j.celrep.2024.114948.","journal-title":"Cell Rep"},{"key":"2325_CR11","doi-asserted-by":"publisher","unstructured":"Wang Y, Sedimbi S, Lofbom L, Singh AK, Porcelli SA, Cardell SL. Unique invariant natural killer T cells promote intestinal polyps by suppressing TH1 immunity and promoting regulatory T cells. Mucosal Immunol. 2018;11:131\u2013143. https:\/\/doi.org\/10.1038\/mi.2017.34","DOI":"10.1038\/mi.2017.34"},{"key":"2325_CR12","doi-asserted-by":"publisher","unstructured":"Wang Y, Bhave MS, Yagita H, Cardell SL. Natural killer T-cell agonist alpha-galactosylceramide and PD-1 blockade synergize to reduce tumor development in a preclinical model of colon cancer. Front Immunol. 2020;11:581301. https:\/\/doi.org\/10.3389\/fimmu.2020.581301.","DOI":"10.3389\/fimmu.2020.581301"},{"key":"2325_CR13","doi-asserted-by":"publisher","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013W102. https:\/\/doi.org\/10.1093\/nar\/gkx247.","DOI":"10.1093\/nar\/gkx247"},{"key":"2325_CR14","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607-D613. doi: [10.1093\/nar\/gky1131].","DOI":"10.1093\/nar\/gky1131"},{"key":"2325_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.7150\/jca.22962","volume":"9","author":"C Kosmidis","year":"2018","unstructured":"Kosmidis C, Sapalidis K, Koletsa T, Kosmidou M, Efthimiadis C, Anthimidis G, et al. Interferon-gamma and Colorectal Cancer: an up-to date. J Cancer. 2018;9:232\u20138. https:\/\/doi.org\/10.7150\/jca.22962.","journal-title":"J Cancer"},{"key":"2325_CR16","doi-asserted-by":"publisher","unstructured":"Du W, Frankel TL, Green M, Zou W. IFNgamma signaling integrity in colorectal cancer immunity and immunotherapy. Cell Mol Immunol. 2022;19:23\u201332. https:\/\/doi.org\/10.1038\/s41423-021-00735-3","DOI":"10.1038\/s41423-021-00735-3"},{"key":"2325_CR17","doi-asserted-by":"publisher","unstructured":"Tang Y, Wei J, Ge X, Yu C, Lu W, Qian Y et al. Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer. Cancer Lett. 2024;588:216798. https:\/\/doi.org\/10.1016\/j.canlet.2024.216798","DOI":"10.1016\/j.canlet.2024.216798"},{"key":"2325_CR18","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1172\/JCI69672","volume":"124","author":"SH Choi","year":"2014","unstructured":"Choi SH, Kim BG, Robinson J, Fink S, Yan M, Sporn MB, et al. Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis. J Clin Invest. 2014;124:2472\u201382. https:\/\/doi.org\/10.1172\/JCI69672","journal-title":"J Clin Invest"},{"key":"2325_CR19","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.4049\/jimmunol.167.10.5527","volume":"167","author":"AI Roberts","year":"2001","unstructured":"Roberts AI, Lee L, Schwarz E, Groh V, Spies T, Ebert EC, et al. Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol. 2001;167:5527\u201330. https:\/\/doi.org\/10.4049\/jimmunol.167.10.5527.","journal-title":"J Immunol"},{"key":"2325_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cyto.2008.01.003","volume":"42","author":"C Zhang","year":"2008","unstructured":"Zhang C, Zhang J, Niu J, Zhang J, Tian Z. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1\/2 phosphorylation. Cytokine. 2008;42:128\u201336. https:\/\/doi.org\/10.1016\/j.cyto.2008.01.003.","journal-title":"Cytokine"},{"key":"2325_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.mucimm.2023.03.006","volume":"16","author":"G Lattanzi","year":"2023","unstructured":"Lattanzi G, Strati F, Diaz-Basabe A, Perillo F, Amoroso C, Protti G, et al. iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis. Mucosal Immunol. 2023;16:326\u201340. https:\/\/doi.org\/10.1016\/j.mucimm.2023.03.006.","journal-title":"Mucosal Immunol"},{"key":"2325_CR22","doi-asserted-by":"publisher","unstructured":"Lee SW, Park HJ, Kim N, Hong S. Natural Killer Dendritic Cells Enhance Immune Responses Elicited by alpha -Galactosylceramide-Stimulated Natural Killer T Cells. Biomed Res Int. 2013; 2013:460706. https:\/\/doi.org\/10.1155\/2013\/460706","DOI":"10.1155\/2013\/460706"},{"key":"2325_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1365-3083.2011.02607.x","volume":"75","author":"K Yoshioka","year":"2012","unstructured":"Yoshioka K, Ueno Y, Tanaka S, Nagai K, Onitake T, Hanaoka R, et al. Role of natural killer T cells in the mouse colitis-associated colon cancer model. Scand J Immunol. 2012;75:16\u201326. https:\/\/doi.org\/10.1111\/j.1365-3083.2011.02607.x.","journal-title":"Scand J Immunol"},{"key":"2325_CR24","doi-asserted-by":"crossref","unstructured":"Laroui H, Ingersoll SA, Liu HC, Baker MT, Ayyadurai S, Charania MA et al. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PLoS One. 2012; 7:e32084. doi: [10.1371\/journal.pone.0032084].","DOI":"10.1371\/journal.pone.0032084"},{"key":"2325_CR25","doi-asserted-by":"publisher","unstructured":"Hosomi S, Grootjans J, Tschurtschenthaler M, Krupka N, Matute JD, Flak MB et al. Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation. J Exp Med. 2017;214:2985\u20132997. https:\/\/doi.org\/10.1084\/jem.20162041","DOI":"10.1084\/jem.20162041"},{"key":"2325_CR26","doi-asserted-by":"publisher","unstructured":"Klingler S, Hsu KS, Hua G, Martin ML, Adileh M, Baslan T et al. Disruption of the crypt niche promotes outgrowth of mutated colorectal tumor stem cells. JCI Insight. 2022;7. https:\/\/doi.org\/10.1172\/jci.insight.153793","DOI":"10.1172\/jci.insight.153793"},{"key":"2325_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01979-x","author":"B Wu","year":"2024","unstructured":"Wu B, Zhang B, Li B, Wu H, Jiang M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-01979-x.","journal-title":"Signal Transduct Target Ther"},{"key":"2325_CR28","doi-asserted-by":"publisher","unstructured":"Liu YT, Sun ZJ. Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics. 2021;11:5365\u20135386. https:\/\/doi.org\/10.7150\/thno.58390","DOI":"10.7150\/thno.58390"},{"key":"2325_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature13150","volume":"509","author":"T Olszak","year":"2014","unstructured":"Olszak T, Neves JF, Dowds CM, Baker K, Glickman J, Davidson NO, et al. Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature. 2014;509:497\u2013502. https:\/\/doi.org\/10.1038\/nature13150","journal-title":"Nature"},{"key":"2325_CR30","doi-asserted-by":"publisher","unstructured":"Lee SW, Park HJ, Van Kaer L, Hong S. Role of CD1d and iNKT cells in regulating intestinal inflammation. Front Immunol. 2023;14:1343718. https:\/\/doi.org\/10.3389\/fimmu.2023.1343718","DOI":"10.3389\/fimmu.2023.1343718"},{"key":"2325_CR31","doi-asserted-by":"publisher","unstructured":"Hudson WH, Gensheimer J, Hashimoto M, Wieland A, Valanparambil RM, Li P et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1(+) stem-like CD8(+) T cells during chronic infection. Immunity. 2019;51:1043\u20131058 e4. https:\/\/doi.org\/10.1016\/j.immuni.2019.11.002","DOI":"10.1016\/j.immuni.2019.11.002"},{"key":"2325_CR32","doi-asserted-by":"publisher","unstructured":"Waibl Polania J, Hoyt-Miggelbrink A, Tomaszewski WH, Wachsmuth LP, Lorrey SJ, Wilkinson DS et al. Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity. 2025;58:232\u2013246 e6. https:\/\/doi.org\/10.1016\/j.immuni.2024.11.026","DOI":"10.1016\/j.immuni.2024.11.026"},{"key":"2325_CR33","doi-asserted-by":"publisher","unstructured":"Kim J, Chang DY, Lee HW, Lee H, Kim JH, Sung PS et al. Innate-like cytotoxic function of bystander-activated CD8(+) T cells is associated with liver injury in acute hepatitis A. Immunity. 2018;48:161\u2013173 e5. https:\/\/doi.org\/10.1016\/j.immuni.2017.11.025","DOI":"10.1016\/j.immuni.2017.11.025"},{"key":"2325_CR34","doi-asserted-by":"publisher","first-page":"101567","DOI":"10.1016\/j.xcrm.2024.101567","volume":"5","author":"KJ Lee","year":"2024","unstructured":"Lee KJ, Choi D, Tae N, Song HW, Kang YW, Lee M, et al. IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy. Cell Rep Med. 2024;5:101567. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101567.","journal-title":"Cell Rep Med"},{"key":"2325_CR35","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1172\/JCI124884","volume":"129","author":"V Langer","year":"2019","unstructured":"Langer V, Vivi E, Regensburger D, Winkler TH, Waldner MJ, Rath T, et al. IFN-gamma drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. J Clin Invest. 2019;129:4691\u2013707. https:\/\/doi.org\/10.1172\/JCI124884","journal-title":"J Clin Invest"},{"key":"2325_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.celrep.2013.02.020","volume":"3","author":"T Chu","year":"2013","unstructured":"Chu T, Tyznik AJ, Roepke S, Berkley AM, Woodward-Davis A, Pattacini L, et al. Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Rep. 2013;3:701\u20138. https:\/\/doi.org\/10.1016\/j.celrep.2013.02.020.","journal-title":"Cell Rep"},{"key":"2325_CR37","doi-asserted-by":"publisher","unstructured":"Perez C, Prajapati K, Burke B, Plaza-Rojas L, Zeleznik-Le NJ, Guevara-Patino JA. NKG2D signaling certifies effector CD8 T cells for memory formation. J Immunother Cancer. 2019;7:48. https:\/\/doi.org\/10.1186\/s40425-019-0531-2","DOI":"10.1186\/s40425-019-0531-2"},{"key":"2325_CR38","doi-asserted-by":"publisher","unstructured":"Dai C, Lin F, Geng R, Ge X, Tang W, Chang J et al. Implication of combined PD-L1\/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer. Oncotarget. 2016;7:10332-44. https:\/\/doi.org\/10.18632\/oncotarget.7243","DOI":"10.18632\/oncotarget.7243"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02325-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:42:14Z","timestamp":1785498134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02325-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2325"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02325-3","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the guidelines on the care and use of laboratory animals approved by the Institutional Animal Care and Use Committee of Sejong University (protocol code SJ-20190301E1, approved on June 5, 2020).","order":2,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"181"}}